ZIVO Bioscience Inc. (ZIVO)
19.50
-0.30 (-1.52%)
At close: Mar 03, 2025, 10:59 AM
No 1D chart data available
| Bid | n/a |
| Market Cap | 72.89M |
| Revenue (ttm) | 86.61K |
| Net Income (ttm) | -15.01M |
| EPS (ttm) | -4.83 |
| PE Ratio (ttm) | -4.04 |
| Forward PE | -15.72 |
| Analyst | n/a |
| Ask | n/a |
| Volume | 2,300 |
| Avg. Volume (20D) | 1,162 |
| Open | 19.80 |
| Previous Close | 19.80 |
| Day's Range | 19.50 - 19.80 |
| 52-Week Range | 3.13 - 22.15 |
| Beta | 0.14 |
About ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniq...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 15, 2003
Employees 8
Stock Exchange NASDAQ
Ticker Symbol ZIVO
Website https://www.zivobioscience.com
Next Earnings Release
ZIVO Bioscience Inc. is scheduled to release its earnings on Mar 14, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · businesswire.com
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing OpportunitiesBLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates...
